Updated: January 21, 2026
How to Save Money on Leqvio in 2026: Coupons, Discounts, and Patient Assistance
Author
Peter Daggett

Summarize with AI
- How Much Does Leqvio Actually Cost?
- Option 1: The Leqvio Co-Pay Program (Commercial Insurance)
- Option 2: What Most Insurance Patients Actually Pay
- Option 3: Medicare Coverage for Leqvio
- Option 4: Novartis Patient Assistance Foundation
- Option 5: NeedyMeds and Other Assistance Resources
- Will Leqvio Have a Generic?
- Bottom Line: What You'll Likely Pay
Leqvio costs over $3,600 per injection. Here's how the Leqvio Co-Pay Program, Novartis patient assistance, and Medicare coverage can reduce your costs to $0.
Leqvio (inclisiran) has a list price of approximately $3,652–$3,731 per injection. At two injections per year (after the loading phase), that's over $7,000 annually at full price. But most patients pay far less than that — and many pay nothing. Here's a complete breakdown of every savings option available in 2026.
How Much Does Leqvio Actually Cost?
Leqvio's retail price is approximately $3,652–$3,731 for a single 284 mg/1.5 mL prefilled syringe. The first year requires three injections (Month 0, Month 3, Month 9), making the first-year list price roughly $9,750–$11,200. After year one, it's two injections per year, or about $7,300–$7,500 annually.
There is no generic version of Leqvio available as of 2026. However, insurance and patient assistance programs dramatically reduce what most patients actually pay.
Option 1: The Leqvio Co-Pay Program (Commercial Insurance)
If you have commercial (employer or private) insurance, you may be eligible for the Leqvio Co-Pay Program, which can reduce your out-of-pocket cost to as little as $0 per treatment. No financial information is required to enroll.
How to enroll:
- Visit leqvio.com and click on the savings section
- Call the Leqvio Service Center at 1-833-537-8462
- Ask your doctor's office to enroll you when setting up your prior authorization
Important: The Co-Pay Program is not valid for patients with Medicare, Medicaid, or any government-funded healthcare programs. Per-treatment maximums and an annual benefit cap apply.
Option 2: What Most Insurance Patients Actually Pay
Even without the co-pay card, Leqvio is covered generously by most commercial insurance plans. According to Novartis:
- 92% of patients with insurance have confirmed medical benefit coverage
- 75% of commercial insurance patients pay less than $10 per treatment
- More than 50% pay $0 per treatment
Leqvio is billed under the medical benefit (not the pharmacy benefit), using HCPCS code J1306. This means it goes through your medical insurance the same way an in-office procedure does, rather than running through a pharmacy.
Option 3: Medicare Coverage for Leqvio
Medicare typically covers Leqvio under Part B as a physician-administered drug. After meeting the Part B deductible ($257 in 2025), Medicare pays 80% of the allowed amount. Patients with a Medigap supplemental plan (like Plan G or Plan N) may have their 20% coinsurance covered, potentially bringing their out-of-pocket cost to $0.
Medicare Advantage plans generally also cover Leqvio, but coverage terms vary. Always check your specific plan before scheduling your injection. The Leqvio Co-Pay Card is NOT available to Medicare patients.
Option 4: Novartis Patient Assistance Foundation
For patients who are uninsured or underinsured and meet income eligibility requirements, the Novartis Patient Assistance Foundation may provide Leqvio at no charge. To apply:
- Visit pap.novartis.com
- Call the Leqvio Service Center at 1-833-537-8462
Eligibility is based on household income and lack of adequate insurance coverage. Applications require proof of income and a doctor's prescription.
Option 5: NeedyMeds and Other Assistance Resources
NeedyMeds.org is a free database that can help you identify additional patient assistance programs for Leqvio. Organizations like the Patient Advocate Foundation and RxAssist may also provide financial assistance or guidance for accessing high-cost specialty drugs.
Will Leqvio Have a Generic?
Not anytime soon. Leqvio is a biologic-class drug (siRNA), and biosimilar development timelines for biologics are typically 10–15 years after initial approval. There is no generic or biosimilar inclisiran expected before the early 2030s.
Bottom Line: What You'll Likely Pay
Most commercially insured patients pay $0–$10 per injection thanks to the Co-Pay Program and strong medical benefit coverage. Medicare patients with Medigap often pay $0. Only truly uninsured patients need to worry about the retail list price — and the Novartis PAP can help even them.
Finding a clinic near you that administers Leqvio is just as important as managing costs. medfinder can call providers in your area to find out who has Leqvio in stock and can schedule your injection.
Read our full access guide: How to Find Leqvio In Stock Near You.
Frequently Asked Questions
Most commercially insured patients pay very little for Leqvio. According to Novartis, 75% of commercial insurance patients pay less than $10 per injection, and over 50% pay $0. With the Leqvio Co-Pay Program, eligible commercial patients can pay as little as $0. Leqvio is covered under the medical benefit, not the pharmacy benefit.
Yes. Medicare Part B generally covers Leqvio as a physician-administered drug (HCPCS code J1306). After the Part B deductible ($257 in 2025), Medicare pays 80% of the approved amount. Patients with Medigap supplemental plans often pay $0 out of pocket. The Leqvio Co-Pay Card is not available to Medicare beneficiaries.
Yes. The Novartis Patient Assistance Foundation (pap.novartis.com) may provide Leqvio at no charge for eligible uninsured or underinsured patients who meet income requirements. Contact the Leqvio Service Center at 1-833-537-8462 to begin the application process.
No. As of 2026, there is no generic version of Leqvio (inclisiran). It is a biologic/siRNA drug, and biosimilar versions are not expected before the early 2030s. The Leqvio Co-Pay Program and patient assistance programs are the main ways to reduce out-of-pocket costs while a generic is unavailable.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Leqvio also looked for:
More about Leqvio
32,900 have already found their meds with Medfinder.
Start your search today.





